Compagnie Lombard Odier SCmA’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-210,896
| Closed | -$65.7M | – | 439 |
|
|
2025
Q1 | $65.7M | Buy |
+210,896
| New | +$62.3M | 0.81% | 36 |
|
|
2024
Q1 | – | Sell |
-134,692
| Closed | -$38.8M | – | 487 |
|
|
2023
Q4 | $38.8M | Sell |
134,692
-5,609
| -4% | -$1.53M | 0.72% | 40 |
|
|
2023
Q3 | $37.7M | Buy |
+140,301
| New | +$35M | 0.87% | 31 |
|
|
2023
Q2 | – | Sell |
-130,665
| Closed | -$31.6M | – | 586 |
|
|
2023
Q1 | $31.6M | Buy |
130,665
+12,828
| +11% | +$3.15M | 0.79% | 36 |
|
|
2022
Q4 | $31M | Sell |
117,837
-96,598
| -45% | -$25.9M | 0.83% | 35 |
|
|
2022
Q3 | $48.3M | Buy |
214,435
+41,174
| +24% | +$9.98M | 1.39% | 21 |
|
|
2022
Q2 | $42.1M | Buy |
173,261
+11,384
| +7% | +$2.79M | 1.07% | 30 |
|
|
2022
Q1 | $39.1M | Buy |
161,877
+62,444
| +63% | +$14.3M | 0.83% | 36 |
|
|
2021
Q4 | $22.4M | Buy |
99,433
+23,375
| +31% | +$4.93M | 0.44% | 49 |
|
|
2021
Q3 | $16.2M | Buy |
76,058
+446
| +0.6% | +$103K | 0.35% | 56 |
|
|
2021
Q2 | $18.4M | Sell |
75,612
-5,641
| -7% | -$1.39M | 0.41% | 50 |
|
|
2021
Q1 | $20.2M | Sell |
81,253
-5,313
| -6% | -$1.27M | 0.45% | 48 |
|
|
2020
Q4 | $19.9M | Buy |
86,566
+4,265
| +5% | +$983K | 0.51% | 44 |
|
|
2020
Q3 | $20.9M | Sell |
82,301
-117
| -0.1% | -$29K | 0.62% | 38 |
|
|
2020
Q2 | $19.4M | Buy |
82,418
+151
| +0.2% | +$34.5K | 0.65% | 36 |
|
|
2020
Q1 | $16.7M | Buy |
82,267
+859
| +1% | +$188K | 0.7% | 39 |
|
|
2019
Q4 | $19.6M | Buy |
81,408
+1,176
| +1% | +$259K | 0.75% | 34 |
|
|
2019
Q3 | $15.5M | Sell |
80,232
-5,277
| -6% | -$1.01M | 0.65% | 42 |
|
|
2019
Q2 | $15.8M | Buy |
85,509
+4,915
| +6% | +$880K | 0.64% | 44 |
|
|
2019
Q1 | $15.3M | Sell |
80,594
-122,820
| -60% | -$23.5M | 0.63% | 43 |
|
|
2018
Q4 | $39.6M | Buy |
203,414
+840
| +0.4% | +$164K | 1.62% | 18 |
|
|
2018
Q3 | $42M | Buy |
202,574
+4,970
| +3% | +$979K | 1.47% | 19 |
|
|
2018
Q2 | $36.5M | Sell |
197,604
-6,805
| -3% | -$1.2M | 1.34% | 20 |
|
|
2018
Q1 | $34.8M | Sell |
204,409
-206,607
| -50% | -$37.9M | 1.27% | 21 |
|
|
2017
Q4 | $71.5M | Buy |
411,016
+198,464
| +93% | +$35.1M | 1.28% | 18 |
|
|
2017
Q3 | $39.6M | Sell |
212,552
-20,013
| -9% | -$3.55M | 1.41% | 17 |
|
|
2017
Q2 | $40.1M | Sell |
232,565
-1,588
| -0.7% | -$258K | 1.39% | 15 |
|
|
2017
Q1 | $38.4M | Sell |
234,153
-62,672
| -21% | -$10.4M | 1.3% | 16 |
|
|
2016
Q4 | $43.4M | Buy |
296,825
+9,255
| +3% | +$1.39M | 1.27% | 18 |
|
|
2016
Q3 | $48M | Sell |
287,570
-3,398
| -1% | -$575K | 1.4% | 17 |
|
|
2016
Q2 | $44.3M | Sell |
290,968
-158,854
| -35% | -$24.7M | 1.29% | 18 |
|
|
2016
Q1 | $67.4M | Sell |
449,822
-116,440
| -21% | -$17.3M | 2.06% | 11 |
|
|
2015
Q4 | $91.9M | Buy |
566,262
+57,095
| +11% | +$8.97M | 2.89% | 5 |
|
|
2015
Q3 | $70.4M | Buy |
509,167
+153,287
| +43% | +$24.2M | 2.87% | 5 |
|
|
2015
Q2 | $54.6M | Buy |
355,880
+5,577
| +2% | +$893K | 2.03% | 13 |
|
|
2015
Q1 | $56M | Sell |
350,303
-59,908
| -15% | -$9.44M | 2.11% | 11 |
|
|
2014
Q4 | $65.4M | Sell |
410,211
-345,675
| -46% | -$53.9M | 3.01% | 9 |
|
|
2014
Q3 | $106M | Buy |
755,886
+1,192
| +0.2% | +$156K | 4.28% | 3 |
|
|
2014
Q2 | $89.3M | Buy |
754,694
+18,730
| +3% | +$2.17M | 3.55% | 7 |
|
|
2014
Q1 | $90.8M | Buy |
735,964
+96,018
| +15% | +$11.6M | 3.77% | 4 |
|
|
2013
Q4 | $73.1M | Buy |
+639,946
| New | +$72.8M | 3.08% | 7 |
|
Other funds holding AMGN
Compagnie Lombard Odier SCmA's AMGN Position: Q2 2025 in Review
Compagnie Lombard Odier SCmA sold out of Amgen (AMGN) in Q2 2025, closing a stake of 210,896 shares — an estimated $65.7M sold.
Compagnie Lombard Odier SCmA first reported a position in AMGN in Q4 2013 and held it in 41 quarters. The position peaked at $106M in Q3 2014. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Compagnie Lombard Odier SCmA reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- Compagnie Lombard Odier SCmA sold 210,896 Amgen shares in Q2 2025, an estimated $65.7M.
- Compagnie Lombard Odier SCmA first reported a position in Amgen in Q4 2013 and held it in 41 quarters.
- Compagnie Lombard Odier SCmA's Amgen position peaked at $106M in Q3 2014.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2025, filed 15 Jul 2025.